Vaccine Technology developed by OHSU scientists acquired by industry
, January 25, 2017


1st Time Award Recipients as Faculty, Staff Scientists

Ben Burwitz’s, Staff Scientist new grant

February 11, 2015 - amfAR's Board of Trustees approved the first round of 11 Innovation Grants totaling close to $2 million. One of the new grants will support a study by Dr. Benjamin Burwitz of Oregon Health & Science University in Portland that could help determine the precise mechanism of action that led to the first and only known HIV cure in "the Berlin patient." The cure was the result of a stem cell transplant involving donated cells with a genetic mutation rendering them impervious to HIV infection. Dr. Burwitz and colleagues plan to generate a non-human primate model that will allow the testing of many hypotheses concerning the Berlin patient's cure, as well as, for example, gene therapy interventions designed to cure HIV.